Form 8-K - Current report:
SEC Accession No. 0001193125-24-148107
Filing Date
2024-05-28
Accepted
2024-05-28 16:18:30
Documents
15
Period of Report
2024-05-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d836271d8k.htm   iXBRL 8-K 27169
2 EX-3.1 d836271dex31.htm EX-3.1 1748
6 GRAPHIC g836271g0528074534164.jpg GRAPHIC 9197
  Complete submission text file 0001193125-24-148107.txt   178184

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nbix-20240524.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbix-20240524_lab.xml EX-101.LAB 17981
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbix-20240524_pre.xml EX-101.PRE 11265
19 EXTRACTED XBRL INSTANCE DOCUMENT d836271d8k_htm.xml XML 3741
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 24992118
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)